Trademark: 97715850
Word
LUVANTAS
Status
Pending
Status Code
681
Status Date
Thursday, May 2, 2024
Serial Number
97715850
Mark Type
4
Filing Date
Tuesday, December 13, 2022
Published for Opposition
Tuesday, June 4, 2024

Trademark Owner History
Medytox Inc. - Owner At Publication

Classifications
5 Implantable medicines for treating neurological disorders and muscle dystonia; implantable antiaging medicines, namely, botulinum toxin for medical use for treatment of facial wrinkles; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain
The wording "LUVANTAS" has no meaning in a foreign language

Trademark Events
Dec 16, 2022
New Application Entered
Dec 28, 2022
Assigned To Examiner
Dec 16, 2022
New Application Office Supplied Data Entered
Jan 5, 2023
Notification Of Non-Final Action E-Mailed
Jan 5, 2023
Non-Final Action Written
Jan 5, 2023
Non-Final Action E-Mailed
Mar 21, 2023
Teas Response To Office Action Received
Apr 26, 2023
Approved For Pub - Principal Register
Mar 21, 2023
Correspondence Received In Law Office
Mar 21, 2023
Teas/Email Correspondence Entered
May 10, 2023
Notification Of Notice Of Publication E-Mailed
May 30, 2023
Published For Opposition
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 19, 2024
Sou Extension 1 Filed
Jul 25, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 19, 2024
Sou Teas Extension Received
Jan 19, 2024
Sou Extension 1 Granted
Apr 25, 2024
Petition To Director - Change Basis - Granted
Jan 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 29, 2024
Teas Petition To Amend Basis Received
Apr 23, 2024
Assigned To Petition Staff
May 2, 2024
Notice Of Allowance Cancelled
Apr 25, 2024
Jurisdiction Restored To Examining Attorney
May 29, 2024
Attorney Review Completed
May 29, 2024
Attorney Review Completed
May 15, 2024
Notification Of Notice Of Publication E-Mailed
May 2, 2024
Case Returned To Examination

Trademark Alertz updated from USPTO on 2030-01-24